In a landmark deal, AstraZeneca has licensed a suite of next-generation weight-loss drugs from China's CSPC, aiming to challenge the dominance of Lilly and Novo Nordisk with longer-acting monthly injectables.
A new industry analysis reveals the apparel and textiles sector is falling dangerously behind on its climate commitments, with progress too slow to meet critical international targets.
The educational streaming service CuriosityStream Inc. (NASDAQ: CURI) is drawing strong analyst support following robust Q3 2025 results, with a consensus 'Strong Buy' rating and a $6 price target highlighting significant growth potential from its current trading level.
AI cloud provider CoreWeave faces a critical juncture as a massive equity investment from chip giant Nvidia clashes with securities class actions alleging the company misled investors about its operational capacity and supplier dependencies.
Envision Energy will supply its high-capacity EN-226 turbines for a 128MW nearshore wind cluster in Vietnam, marking a significant step in the country's Power Development Plan VIII and setting a potential benchmark for regional offshore development.
Despite reporting a 22% surge in Q4 2025 net income to $4.1 billion, global payments giant Mastercard is cutting approximately 1,400 jobs as part of a strategic review, highlighting the complex balance between growth and operational efficiency in the fintech sector.
BEN finalizes a landmark AI licensing framework for Africa and a university wellbeing pilot while bolstering its balance sheet through capital raises and debt conversion, prompting analysts to question if execution is now the priority.
Klarna Group faces a dual challenge: surging commercial demand for its 'buy now, pay later' services and intensifying legal scrutiny over alleged IPO disclosure failures regarding credit risk. The stock's sharp decline shifts investor focus to upcoming quarterly results and credit quality metrics.
Amazon is reportedly negotiating a landmark investment of up to $50 billion in OpenAI, a move that would reshape the AI landscape and intensify its cloud rivalry with Microsoft and Google. The potential deal highlights the soaring costs of competing in generative AI and could redefine Amazon Web Services' strategy.
The new campus in McBee, SC, aims to bolster North American supply chains for critical minerals, starting with a 2,000-ton annual processing capacity for magnet scrap.
Abigail Fisher, a seasoned HR leader with two decades of experience, is set to rejoin Grant Thornton UK in late February as its inaugural Chief People Officer, signaling a renewed focus on culture and talent.
The $7.6 billion RIA has expanded its internal equity plan to 29 employee-owners, formalizing a decade-long succession strategy that aims to preserve independence as co-founder Barry Ritholtz nears 65.
Eli Lilly commits $85 million upfront and over $1.8 billion in potential milestones to partner with Repertoire Immune Medicines, aiming to develop a new class of 'tolerizing' therapies that reset the immune system without broad suppression.
Exclusive: A newly revealed State Department cable directs embassies worldwide to audit all assistance programs against stringent new rules prohibiting funding for groups involved in abortion services, diversity initiatives, and gender identity advocacy, expanding a long-contested policy to nearly $30 billion in foreign aid.
A U.S. Navy destroyer has docked at Israel's southern port of Eilat, a move reported by Israeli media as U.S.-Iranian tensions simmer. While officials describe the deployment as routine, it coincides with a significant American military buildup in the region.
Starbucks is overhauling its popular Rewards program for over 35 million U.S. members, introducing a tiered structure (Green, Gold, Reserve) designed to offer faster, more personalized benefits and deeper integration with travel partners.
Despite recent market turbulence, a surge in eurozone business confidence is spotlighting companies where high insider ownership aligns management with shareholder interests. We examine three such firms poised for growth.
Mining giant Rio Tinto and state-owned Aluminum Corporation of China (Chalco) have entered a definitive agreement to acquire a controlling 68.6% stake in Brazil's Companhia Brasileira de Alumínio (CBA) from Votorantim, valuing the deal at approximately $902.6 million. The move signals a major consolidation in the global low-carbon aluminum sector.
Multiple company directors at the UK hydrogen power specialist have invested heavily in its stock over the past year, a move often interpreted as a bullish signal on future prospects, despite the shares trading significantly higher now.
Summit Therapeutics (SMMT) finds itself at a crossroads, with its stock down over 30% in the past year. Conflicting signals from valuation models paint a complex picture: is the biotech firm dramatically overvalued on traditional metrics, or deeply undervalued based on future cash flows?
